"Alvogen and Pfenex’ PF708 (biosimilar, teriparatide) Receives FDA’s Approval for the Treatment of Osteoporosis @alvogenpr @Pfenex https://t.co/8CBAeOpklg"

PF708 (teriparatide biosimilar) - China NT Pharma, Pfenex

Oct 7, 2019